<html>
  <head>
    <title>Pathways | ASA is no longer indicated for primary prevention of cardiovascular events</title>
  </head>
  <body>
    <h2>ASA is no longer indicated for primary prevention of cardiovascular events</h2>
    <h4><a class="ajax" href="/specializations/4">Cardiology</a></h4>
    <p class="space no_indent">This 2011 meta-analysis included  more than 100,000 patients. For every 1,000 subjects treated with aspirin over a 5-year period, aspirin would prevent 2.9 major coronary events  and cause 2.8 major bleeds.</p>
    <p class="space no_indent"><a target="_blank" href="http://www.thennt.com/aspirin-to-prevent-a-first-heart-attack-or-stroke/">Decision Tool for ASA in primary prevention</a></p>
    <h6>References</h6>
    <cite>Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials. Am Heart J 2011;162(1):115-124.e2. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/21742097">http://www.ncbi.nlm.nih.gov/pubmed/21742097</a></cite>
    <cite>CMA InfoPOEM March 5, 2012: “ASA: not for primary prevention”</cite>
  </body>
</html>